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Abstract: The excitatory amino acid domoic acid is the causative agent of amnesic 
shellfish poisoning in humans. The in vitro effects of domoic acid on rat neonatal brain Mar. Drugs 2007, 5     114 
 
microglia were compared with E. coli lipopolysaccharide  (LPS), a known activator of 
microglia mediator release over a 4 to 24 hour observation period. LPS [3 ng/mL] but not 
domoic acid [1mM] stimulated a statistically significant increase in TNF-α mRNA and 
protein generation. Furthermore, both LPS and domoic acid did not significantly affect TGF-
β1 gene expression and protein release. Finally, an in vitro exposure of microglia to LPS 
resulted in statistically significant MMP-9 expression and release, thus extending and 
confirming our previous observations. However, in contrast, no statistically significant 
increase in MMP-9 expression and release was observed after domoic acid treatment. Taken 
together our observations do not support the hypothesis that a short term (4 to 24 hours) in 
vitro exposure to domoic acid, at a concentration toxic to neuronal cells, activates rat 
neonatal microglia and the concomitant release of the pro-inflammatory mediators tumor 
necrosis factor-α (TNF-α) and matrix metalloproteinases-9 (MMP-9), as well as the anti-
inflammatory cytokine transforming growth factor β1 (TGF-β1).  
 
Keywords: domoic acid, microglia, tumor necrosis factor-α, TNF-α, transforming growth 
factor  β1, TGF-β1, matrix metalloproteinase-9, LPS, lipopolysaccharide, excitotoxic, 
endotoxin. 
 
 
 
1. Introduction   
  
Cells of hematopoietic origin that migrate into the developing brain during late embryonic, fetal or 
postnatal stages, have been shown to transform into microglia cells as they populate the brain [1,2]. It 
is currently thought that microglia are normally quiescent (resting), but that they can become activated 
in response to the presence of bacteria, viruses or central nervous system injury, upregulating cell 
surface activation antigens and releasing both pro-inflammatory and anti-inflammatory mediators 
[3,4]. 
In vivo as well as in vitro administration of lipopolysaccharide (LPS), a major component of Gram-
negative bacteria which binds to the CD14 receptor, has been shown to potently activate adult and 
neonatal rat microglia (for review see Ref. [4]), resulting in the release of pro- and anti-inflammatory 
products, which include cytokines like TNF-α [5,6] and TGF-β1 [7,8] as well as the protease MMP-9 [5, 
9]. These mediators have been implicated in sublethal and lethal neuronal and glial injury [10] and 
neuronal degeneration [4,11,12] as well as repair [2,13]. 
Exposure to the marine toxin domoic acid, an excitotoxic amino acid structurally similar to kainic 
acid and the neurotransmitter glutamic acid, has been shown to cause amnesic shellfish poisoning in 
humans, a condition that has led to death in some cases [14]. Currently, the Center for Food Safety and 
Applied Nutrition, U.S. Food and Drug Administration, includes amnesic shellfish poisoning as one of the 
“… five recognized fish poisoning syndromes in the United States…”, together with paralytic, neurotoxic, 
diarrhetic, and ciguatera fish poisoning (http://www.cfsan.fda.gov/~comm/haccp4f.html) [15]. Behavioral 
toxicity studies have confirmed that domoic acid is a potent neurotoxin in newborn rats, at doses far 
lower than in adult animals [16,17,18]. Even though hippocampal pyramidal neurons, mossy fiber Mar. Drugs 2007, 5     115 
 
terminals [19,20] and astrocytes [21] appear to be targeted in vivo by domoic acid , recently we 
hypothesized that brain microglia may be involved in the neurotoxicity to domoic acid [22]. 
The possibility that domoic acid might activate neonatal microglia, both in vitro and in vivo, was 
suggested by the observation that kainic acid, a domoic acid and glutamate analog that upregulated the 
microglia scavenger receptor mRNA [23], induced tissue plasminogen activator release [24]. The 
activation of the ionotropic AMPA glutamate GluR4 subunit, which is expressed by activated 
microglia following transient forebrain ischemia in vivo [25], has been proposed as a possible 
explanation for these observations. Thus, because the GluR4 subunit of the AMPA glutamate receptor 
has affinity for domoic acid [26], and we have observed its presence on microglia [27], we 
hypothesized that domoic acid might activate neonatal microglia in vitro [22]. 
The purpose of this investigation was to continue the study of our working hypothesis [22], by 
extending the in vitro exposure of microglia to domoic acid [1mM], a concentration toxic to neuronal 
cells [27], and determining if it would activate microglia and affect both gene expression and release of 
pro- and anti-inflammatory microglia products TNF-α [5,6], MMP-9 [5,9], and TGF-β1 [7,8], in a time-
dependent manner. Our present study provides experimental evidence that in contrast to LPS [3-10ng/mL] 
in vitro, which we have shown stimulates TNF-α and MMP-9 release from microglia [5,27], a 4 to 24 
hour in vitro exposure to domoic acid [1mM] does not appear to activate neonatal rat microglia and the 
concomitant expression and release of pro- and anti-inflammatory mediators TNF-α, MMP-9, and 
TGF-β1. 
 
2. Results and Discussion 
 
2.1 Determination of domoic acid by nuclear magnetic resonance 
 
As described in Experimental, the stability of the stock solution of domoic acid (12.5 mM) used in 
the experiments was determined by nuclear magnetic resonance (NMR).  
As shown in Figure 1, the proton NMR spectrum of the sample was consistent with the expected 
NMR pattern for a pure sample of domoic acid. The proton NMR spectrum showed a methyl doublet 
at 1.19 ppm, an olefinic methyl singlet at 1.74 ppm, three olefinic signals corresponding to the 1,1,4-
trisubstituted butadiene system at 6.29 (dd), 6.06 (d) and 5.71 (dd) ppm, four methine signals at 3.91 
(d), 3.76 (ddd), 3.22 (dq) and 2.98 (m) ppm, and four signals for two methylene groups at 3.64 (dd), 
3.43 (dd), 2.67 (dd) and 2.43 (dd) ppm. The spectrum did not show other additional signals 
corresponding to any domoic acid degradation compounds. These data confirmed the presence of pure 
domoic acid in the sample which was analyzed and which was used in the experiments described 
herein.  
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Figure 1. Proton nuclear magnetic resonance spectrum of domoic acid (DOM). 
 
 
    
 
2.2 Effect of LPS and domoic acid on TNF-α mRNA expression by rat neonatal microglia 
 
We have previously reported that in vitro stimulation of microglia with LPS [10ng/mL] will result in 
TNF-α mRNA expression [27]. As shown in Figure 2A, while untreated (control) microglia did not 
express TNF-α, stimulation with LPS [3 ng/ml] resulted in a time-dependent increase in TNF-α 
mRNA expression relative to controls as determined by semi-quantitative RT-PCR within the linear 
range of amplification (25 cycles) after 4 hours. In contrast, as shown in Figure 2B, domoic acid 
[1mM] induced only minor changes in TNF-α mRNA expression at the 4 hour time point.  
Furthermore, as shown in Figure 3, LPS [3 ng/mL] induced statistically significant levels of TNF-α 
expression: 1.77±0.3 and 1.78±0.2 fold increase relative to controls by 4 and 8 hours, respectively, P< 
0.05, and then a progressive decline to 1.54±0.14 and 1.27±0.18 fold increase relative to controls by 16 
and 24 hours, respectively, P>0.05. Noteworthy was the observation that TNF-α expression at 4 hours 
was lower than that we reported with LPS [10 ng/mL] previously [27]. In contrast, as shown in Figure 
3, domoic acid [1mM] induced only minor non-statistically significant changes in levels of TNF-α 
expression relative to controls: 1.22±0.1 fold by 4 hours, then a decrease to 0.94±0.02 fold and 
1.01±0.05 fold by 8 and 16 hours, respectively, while slightly increasing to 1.37±0.25 fold by 24 
hours. 
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Figure 2. RT-PCR analysis of TNF-α gene expression in rat neonatal microglia after in vitro 
treatment with LPS or DOM. Neonatal rat brain microglia (2.8-5.0 x 10
6 cells/culture dish) were 
treated with (A) LPS [3 ng/mL] or (B) DOM [1mM] for 4 to 24 hours as described in 
Experimental. Amplification of TNF-α and S12 mRNAs shows the predicted cDNA size after 
separation on a 1.5 % agarose gel and visualization by SYBR
R Gold nucleic acid staining. The 
S12 ribosomal RNA gene product was amplified for 25 and 30 cycles and demonstrated equal 
loading of the gels. Quantification of the TNF-α product was done after 25 cycles, where mRNA 
expression was observed to be in the linear range. The figure depicts one of two similar 
experiments.  
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 Figure 3. Time-dependent TNF-α gene expression levels in rat neonatal microglia after in vitro 
treatment with LPS or DOM. Levels of gene expression were quantified as described in 
Experimental, and were normalized to S12 ribosomal RNA. Relative expression levels were 
calculated by dividing the experimental level at each time point by the level observed in the 
control. Expression is relative to steady-state levels in control (1.00). Data (relative expression 
level) is expressed as mean ± SE of 2 independent experiments. *P < 0.05 vs. vehicle control. 
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2.3 Effect of LPS and domoic acid on TNF-α release by rat neonatal microglia 
 
We have shown that in vitro stimulation of microglia with LPS will lead to TNF-α generation 
[5,27]. In order to determine whether a 4 to 24 hour stimulation of microglia with LPS [3 ng/mL] or 
domoic acid [1mM] leads to TNF-α protein secretion, cell-free media from the same cell culture dishes 
containing microglia used for TNF-α mRNA analysis shown in Figure 2 and 3, were assayed for 
TNF-α release with an ultrasensitive rat-specific ELISA (See Experimental). As shown in Figure 4, 
LPS [3 ng/mL] stimulated statistically significant TNF-α release: at 4, 8, 16 and 24 hours TNF-α 
levels were 16,242 ± 2,417, 23,792 ± 3739, 12,503 ± 3,446, 12,025±3,517 pg/mL (n=4), respectively, 
vs. 44.2 ± 8.6 pg/mL (untreated controls, n=9), P < 0.01. In contrast, TNF-α levels in the culture media 
in domoic acid [1mM]-treated microglia remained unchanged, although a non-statistically significant 
66% increase of immunoreactive TNF-α release was observed at 4 hours: 45 ± 8.36 pg/mL (domoic 
acid-treated, n=6) vs. 27 ± 5.4 pg/mL ( untreated controls, n=9) , P > 0.05. Interestingly, as shown in 
Figure 2B and Figure 3, 4 hours after domoic acid treatment of microglia, a slightly elevated though 
non-statistically significant increase in TNF-α mRNA expression was observed. 
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Figure 4. Time-dependent effect of LPS and DOM on rat neonatal microglia TNF-α 
release. Rat neonatal microglia (2.8-5.0 x 10
6 cells/culture dish) were treated with LPS [3 
ng/mL] or DOM [1mM] for 4 to 24 hours. TNF-α was determined as described in 
Experimental. Data (pg/mL) show the mean ± SE of 4-9 independent experiments. ** P < 
0.01 vs. vehicle control. 
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2.4 Effect of LPS and domoic acid on TGF-β1 mRNA expression by rat neonatal microglia 
 
Activation of microglia has been shown to cause the release of the anti-inflammatory cytokine TGF-
β1 [7,8]. As shown in Figure 5A, untreated (control) microglia showed constitutive TGF-β1 mRNA 
expression. Interestingly, stimulation of microglia with LPS [3 ng/ml] resulted in a time-dependent 
decrease in TGF-β1 mRNA expression relative to controls as determined by semi-quantitative RT-
PCR within the linear range of amplification (25 cycles). In contrast, as shown in Figure 5B, domoic 
acid [1mM] did not appear to affect basal TGF-β1 mRNA expression as determined by semi-
quantitative RT-PCR over the linear range of amplification (25 cycles).  
Furthermore, as shown in Figure 6, LPS [3 ng/mL] induced non-statistically significant alterations 
in TGF-β1 expression levels relative to controls which were 0.931±0.19 fold by 4 hours, 0.901±0.22 
fold by 8 hours, then slightly decreasing to 0.671±0.05 fold by 16 hours, and returning to near control 
levels (0.821±0.15 fold) by 24 hours. Similarly, domoic acid [1mM] induced non-statistically 
significant alterations in levels of TGF-β1 expression which were 0.625 fold by 4 hours (n=1) and 
0.923±0.09, 1.01±0.1 fold and 0.977±0.206 fold by 8, 16 and 24 hours, respectively. 
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Figure 5. RT-PCR analysis of TGF-β1 gene expression in rat neonatal microglia after in vitro 
treatment with LPS or DOM. Rat neonatal microglia (2.8-5.0 x 10
6 cells/culture dish) were 
treated with (A) LPS [3 ng/mL] or (B) DOM [1mM] for 4 to 24 hours as described in 
Experimental. Amplification of TGF-β1 and S12 mRNAs showed the predicted cDNA size 
after separation on a 1.5 % agarose gel and visualization by SYBR
R Gold nucleic acid staining. 
The S12 ribosomal RNA gene product was amplified for 25 and 30 cycles and demonstrated 
equal loading of the gels. Quantification of the TGF-β1 product was done after 20 cycles 
shown to be in the linear range. The figure depicts one of two similar experiments. 
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Figure 6. Time-dependent TGF-β1 gene expression levels in rat neonatal microglia after 
in vitro treatment with LPS or DOM. Levels of gene expression were quantified as 
described in Experimental and were normalized to S12 ribosomal RNA. Relative 
expression levels were calculated by dividing the experimental level at each time point by 
the level observed in the control. Expression is relative to steady-state levels in control 
(1.00). Data (relative expression level) is expressed as mean ± SE of 2 independent 
experiments.  
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2.5 Effect of LPS and domoic acid on TGF-β1 release by rat neonatal microglia 
 
 In order to determine whether a 4 to 24 hour stimulation of microglia with domoic acid [1mM] or 
LPS [3 ng/mL] in vitro caused TGF-β1 protein release, the cell-free media from the same cell culture 
dishes containing microglia used for TGF-β1 mRNA analysis shown in Figures 5 and 6 were assayed 
with a rat-specific ELISA (see Experimental). As shown in Figure 7, in LPS [3 ng/mL]-treated 
microglia TGF-β1 levels remained unchanged: by 4, 8, 16 and 24 hours TGF-β1 levels were 219.4 ± 
13.3, 267 ± 34.4, 216 ± 19.4, 244 ± 13.0 pg/mL (n=5), respectively vs. 255.3 ± 27.3 pg/mL (untreated 
controls, n=5), P > 0.05. Similarly, in domoic acid [1mM]-treated microglia although TGF-β1 levels 
appeared to decrease after 4, 8, 16 and 24 hours, the differences were non-statistically significant: 198 
± 17, 201 ± 21.4, 173 ± 15.7, 207 ± 27 pg/mL (n=6), respectively, vs. 255.3 ± 27.3 pg/mL (untreated 
controls, n=5), P > 0.05.   
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Figure 7. The time-dependent effect of LPS and DOM on rat neonatal microglia TGF-
β1 release. Rat neonatal microglia (2.8-5.0 x 10
6 cells/culture dish) were treated with 
LPS [3 ng/mL] or DOM [1mM] for 4 to 24 hours. TGF-β1 was determined as described 
in Experimental. Data (pg/mL) are expressed as mean ± SE of 5-6 independent 
experiments.  
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2.6. Effect of LPS and domoic acid on MMP-9 mRNA expression by rat neonatal microglia 
 
Stimulation of microglia has been shown to cause increased expression of the pro-inflammatory 
MMP-9 [9,27]. As shown in Figure 8A, stimulation of microglia with LPS [3 ng/ml] in vitro resulted 
in a time-dependent increase in MMP-9 mRNA expression relative to controls as determined by semi-
quantitative RT-PCR at the linear range of amplification (25 cycles) that was clearly visible by 4 
hours. In contrast, as shown in Figure 8B, domoic acid [1mM] did not induce significant changes in 
MMP-9 mRNA expression as determined by semi-quantitative RT-PCR over the linear range of 
amplification (25 cycles).  
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Figure 8. RT-PCR analysis of MMP-9 gene expression in rat neonatal microglia after in vitro 
treatment with LPS or DOM. Rat neonatal microglia (2.8-5.0 x 10
6 cells/culture dish) were 
treated with (A) LPS [3 ng/mL] or (B) DOM [1mM] for 4 to 24 hours as described in 
Experimental. Amplification of MMP-9 and S12 mRNAs showed the predicted cDNA size 
after separation on a 1.5 % agarose gel and visualization by SYBR
R Gold nucleic acid staining. 
The S12 ribosomal RNA gene product was amplified for 25 and 30 cycles and demonstrated 
equal loading of the gels. Quantification of the MMP-9 product was done after 25 cycles shown 
to be in the linear range. The figure depicts one of two similar experiments. 
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Furthermore, as shown in Figure 9, LPS [3ng/mL] induced a statistically significant increase in the 
level of MMP-9 expression relative to controls beyond 4 hours (1.45±0.09 fold, P>0.05): 2.34±0.33 
fold by 8 hours (P<0.01), and remained significantly elevated at 2.02±0.08 fold and 1.94±0.15 fold at 
16 and 24 hours (P<0.05), respectively. In contrast, domoic acid[1 mM] induced non-statistically 
significant changes in the relative levels of MMP-9 expression: 1.49 fold by 4 hours(n=1), 1.16±0.02 
and 1.13±0.02 fold at 8 and 16 hours, respectively, and then a slight increase to 1.31±0.1 fold by 24 
hours.  
 
Figure 9. Time-dependent MMP-9 gene expression levels in rat neonatal microglia after in 
vitro treatment with LPS or DOM. Levels of gene expression were quantified as described in 
Experimental and were normalized to S12 ribosomal RNA. Relative expression levels were 
calculated by dividing the experimental level at each time point by the level observed in the 
control. Expression is relative to steady-state levels in control (1.00). Data (relative expression 
level) is expressed as mean ± SE of 2 independent experiments. *p < 0.05 or **p < 0.01 vs. 
vehicle control. 
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 2.7 Effect of LPS and domoic acid on MMP-2 and MMP-9 release by rat neonatal microglia 
 
 We have shown that a stimulation of microglia with LPS in vitro will lead to MMP-9 release [5,27]. 
In order to determine whether a 4 to 24 hour stimulation of microglia with LPS [3 ng/mL] or domoic 
acid [1mM] leads to MMP-2 and MMP-9 secretion, cell-free media from the same cell culture dishes 
containing microglia used for MMP-9 mRNA analysis shown in Figures 8 and 9, were assayed for 
MMP-2 and MMP-9 release as described in Experimental. As shown in Figure 10, a statistically 
significant increase in MMP-9 release was observed 8, 16 and 24 hours after microglia were stimulated 
with LPS [3 ng/mL]. MMP-9 inverse optical density levels for 8, 16 and 24 hours were 0.69 ± 0.05, 
0.874 ± 0.06, 0.91 ± 0.0005 (LPS-treated, n=2), respectively, vs. 0.46 ± 0.03 (untreated controls, n=2), 
P< 0.05 (8 hours) and P < 0.01(16 and 24 hours). In contrast to LPS, MMP-9 levels in the tissue 
culture media in domoic acid-treated microglia remained unchanged 4, 8, 16 and 24 hours after Mar. Drugs 2007, 5     125 
 
domoic acid treatment. Neither LPS nor domoic acid had a significant effect on MMP-2 release over the 
24 hour-observation period.  
 
Figure 10. The time-course of MMP-2 and MMP-9 expression in rat neonatal microglia cultured 
in the presence of LPS or DOM. MMP-2 and MMP-9 were determined as described in 
Experimental. (A) SDS-PAGE zymography, (B) bar-graph depicting the quantitated results. Rat 
neonatal microglia (2.8-5 x 10
6 cells/culture dish) were treated with LPS [3 ng/ml] or DOM [1 
mM] for 4 to 24 hours. Data (inverse O.D. units) are expressed as mean + SE of 2 independent 
experiments. *p < 0.05 or **p < 0.01 vs. vehicle control. 
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3. Discussion  
 
While the excitotoxicity of domoic acid to adult neuronal tissue in humans, rats, mice and monkeys 
is well documented (for review see Ref [22]), there is also a growing literature supporting the notion 
that the neonatal period is particularly sensitive [16,17,18] perhaps because the blood-brain barrier is 
incomplete [28]. Furthermore, because the GluR4 subunit of the AMPA glutamate receptor has affinity Mar. Drugs 2007, 5     126 
 
for domoic acid [26,29,30], is activated in rat microglia in vivo [25] and we have observed its presence 
on rat neonatal microglia in vitro [27], we hypothesized that domoic acid might putatively activate 
neonatal microglia in vitro and lead to concomitant mediator release [22]. Thus, the purpose of this 
investigation was to continue testing our hypothesis [22,27], and determine whether extending the in vitro 
exposure to domoic acid would affect both gene expression and concomitant release of the pro-
inflammatory TNF-α [5, 6] and MMP-9 [5, 9], as well as the anti-inflammatory cytokine TGF-β1 [7, 8]. 
Similar to our previous study [27], and prior to conducting the in vitro studies with rat neonatal 
microglia, we considered it necessary to ascertain the chemical stability of domoic acid. The proton 
NMR spectrum of the domoic acid stock used for the experiments described herein was consistent with 
the expected proton NMR pattern for pure domoic acid, with no evidence of degraded compounds, 
thus confirming the chemical stability of domoic acid in the aqueous solutions frozen to –80°C and 
which were thawed prior to experiments described herein. Interestingly, our observations complement 
reports on domoic acid’s stability in saline solutions [31]. Having determined that our domoic acid 
preparation was stable and undegraded, we then investigated whether a 4 to 24 hour exposure to 1 mM 
domoic acid in vitro would activate rat neonatal microglia pro-inflammatory or anti-inflammatory 
mediator expression and release or perhaps both. 
The significance and contribution of the cytokine TNF-α to the pathogenesis of inflammatory CNS 
disorders in vivo has been studied extensively because this cytokine has been hypothesized to mediate 
myelin and oligodendrocyte damage in vitro [10] and perhaps may be involved in several central nervous 
system pathologies [4,32,33]. Microglia are a source of TNF-α in the brain, an observation first reported 
more than two decades ago [6]. Because E. coli LPS triggers rat neonatal microglia TNF-α gene 
expression and subsequent protein release in vitro [5,34,27] in both a concentration- and time-dependent 
manner, LPS was used as a positive control of microglia activation in all our experiments. In our prior 
study, we reported that a 1 to 6 hour in vitro exposure of rat neonatal microglia to LPS [10 ng/mL] 
resulted in both a statistically significant increase of TNF-α gene expression and protein release [27]. In 
contrast, domoic acid [1 mM] induced a non-statistically significant rise in TNF-α expression and a 
statistically significant increase (p<0.01) of immunoreactive TNF-α protein by 4 hours [27]. In the current 
study, the in vitro exposure of rat microglia to both LPS [3ng/mL] and domoic acid [1mM] was extended 
from 4 to 24 hours. Interestingly, although extending the in vitro exposure of microglia to 3 ng/mL LPS, 
rather than 10 ng/mL as in our previous study [27], resulted in both a statistically significant increase 
in TNF-α gene expression and TNF-α protein release, treatment of microglia in vitro with domoic acid 
[1mM] from 4 to 24 hour, did not lead to statistically significant enhancement of TNF-α gene 
expression and TNF-α protein release. Taken together, our current and previous observations [27] 
suggest that future studies might perhaps benefit from the use of more sensitive methods to investigate 
both TNF-α expression and TNF-α protein release when both are low, as is the case in domoic acid-
treated microglia: real-time PCR techniques would enable the determination of the kinetics of low 
levels of TNF-α expression [35]; while similarly, immuno-PCR would support an analysis of TNF-α 
release at the femtomolar range [36]. These proposed studies might be of considerable significance 
because picogram levels of TNF-α release have been observed after stimulation of rat neonatal 
microglia with kainic acid, a domoic acid and glutamate analog [37]. In summary, and similar to our 
previous observations [27], direct interaction of the marine toxin domoic acid with microglia in vitro 
does not appear to activate significant expression and release of the pro-inflammatory cytokine TNF-α, Mar. Drugs 2007, 5     127 
 
an observation that would appear to differ with the effect of kainic acid, also a glutamate analog, on 
TNF-α release by microglia [37]. Interestingly our current observations support data that suggest that 
neuronal death caused by excitatory amino acids does not require the pro-inflammatory cytokine TNF-
α [38]. 
Transforming growth factor-betas (TGF-betas) are pleiotropic cytokines involved in development 
and maintenance of the nervous system, that may exert potent neuroprotective effects [39]. In vivo 
studies have documented that TGF-β1 mediates neuroprotection against excitotoxic injury [40], a 
finding that contrasts with TGF-β1 “opposite” effects on excitotoxic injury in vitro [41]. Although in 
vivo TGF-β1 mRNA increased in microglial cells of the hippocampus in response to kainic acid-
induced neurodegeneration [42], and in vitro activation of microglia and TNF-α release have been 
shown to mediate the generation of TGF-β1 [7,8], no studies to our knowledge have investigated the in 
vitro effect of kainic acid or domoic acid on brain microglia TGF-β1 gene expression and protein 
release. In the current study, the in vitro exposure of rat microglia to both LPS and domoic acid had no 
statistically significant effect on both TGF-β1 gene expression and protein release over a 24 hour 
observation period, an observation that appears to be in agreement with recent observations with human 
microglia [43]. It would thus appear from our experiments that even though microglia released increased 
amounts of pro-inflammatory TNF-α when exposed to LPS [3 ng/mL] stimulation, these increased levels 
of TNF-α did not alter the expression or release of TGF-β1 within the 4 to 24 hours observation period we 
used in the in vitro protocols of our study. Our current results, do not support the notion that direct 
interaction of the marine excitotoxin domoic acid [1mM] with microglia in vitro leads to the 
generation of the anti-inflammatory cytokine TGF-β1. Our findings however do not preclude the 
possibility that similar experimental conditions may have affected expression and/or release of 
additional anti-inflammatory cytokines released by microglia, eg. IL-10 [44]. These studies are 
currently underway in our laboratory. 
Proteases such as MMP-9 [5, 9] have been implicated in sublethal and lethal neuronal and glial 
injury in vivo in the CNS [45]. Activation of rat neonatal microglia and release of MMPs after LPS 
treatment in vitro [5] may involve TNF-α [46,47]. While in our previous study we did not investigate 
MMP gene expression, we did report that a 1 to 6 hour in vitro exposure of rat neonatal microglia to both 
LPS [10 ng/mL] and domoic acid [1 mM] resulted in a statistically significant increase of MMP-9 protein 
release [27], although the magnitude of MMP-9 release after domoic acid treatment was much smaller. In 
the current study, the in vitro exposure of rat microglia to both LPS [3ng/mL] and domoic acid [1mM] 
was extended from 4 to 24 hours. Interestingly, the in vitro exposure of microglia to 3 ng/ml LPS, rather 
than 10 ng/ml as used in our prior study [27], still resulted in statistically significant MMP-9 release 
which remained elevated up to 24 hours (P<0.01), thus extending and confirming our previous 
observations. However, in contrast to our earlier report [27], no significant increase in MMP-9 release 
over the 24 hour observation period was observed after domoic acid treatment. Interestingly, 
concomitant MMP-9 gene expression was statistically significant from 8 to 24 hours after exposure to 
LPS, but not after microglia cells were exposed to domoic acid. Thus, our current observations, do not 
appear to provide support to the hypothesis that direct interaction of the marine toxin domoic acid with 
microglia  in vitro leads to the time-dependent generation of the pro-inflammatory matrix 
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In summary, in our experiments the effect of a 4 to 24 hour in vitro exposure to domoic acid on rat 
neonatal microglia activation and concomitant TNF-α, MMP-9 and TGF-β1 gene expression and protein 
release was clearly distinct in its magnitude from that observed after exposure to E. Coli LPS, an agent 
involved in endotoxic shock and other central nervous pathologies [4]. Even though our present study 
was limited to the study of the short term effect (4 to 24 hours) of an in vitro exposure of brain neonatal 
microglia to domoic acid, it provides experimental evidence that domoic acid [1mM] which we 
observed was toxic to neuronal cells [27], does not appear to trigger a significant activation of rat 
neonatal microglia and concomitant gene expression and release of the pro-inflammatory mediators 
TNF-α and MMP-9 , as well as the anti-inflammatory cytokine TGF-β1. Our observations however do 
not exclude the possibility that increased levels of TNF-α, MMP-9 or TGF-β1 may be generated by 
neonatal rat microglia as a result of either, (1) a synergistic interaction between domoic acid and subtoxic 
concentrations of excitatory amino acids, a combination that has been shown to increase the neurotoxicity 
of domoic acid to primary cultures of cerebellar neurons [48], or (2), a further increase in the time of in 
vitro exposure to domoic acid, suggested by the observation that domoic acid activates rat microglia 
several days after in vivo administration [49] perhaps as a result of the neuronal toxicity [50] of this 
marine toxin. A complete understanding of the potential neurotoxic and/or neuroprotective effects of 
TNF-α, MMP-9 or TGF-β1, as well as other cytokines [51] and metalloproteinases [52] which we have 
recently shown rat microglia may release upon LPS or domoic acid treatment, will ultimately lead to a 
better understanding of domoic acid’s pathophysiological effects on human microglia. This concept is 
supported by the established fact that glutamate receptors are highly conserved between mammals 
[29].  
 
4. Experimental 
 
4.1. Reagents 
 
LPS B (Escherichia coli 026:B6) was obtained from Difco Laboratories (Detroit, MI); crystalline 
lyophilized domoic acid was purchased from Diagnostics Chemicals Ltd. (Oxford, CT) and  
was dissolved in LPS-free water obtained from GIBCO-BRL (Grand Island, NY) to prepare a 12.5 
mM stock [53] and stored at –80°C. Dulbecco's modified Eagle medium (DMEM) with high glucose 
(4,500 mg/l), Hank’s balanced salt solution (HBSS), penicillin (P), streptomycin (S), trypsin (0.25%)-
EDTA [1mM] and trypan blue were purchased from GIBCO-BRL (Grand Island, NY); certified heat-
inactivated fetal bovine serum (FBS) was obtained from Hyclone (Logan, UT). A LPS stock of 1 mg/ml 
was prepared in a 0.9% sodium chloride non pyrogenic solution from Baxter Healthcare Corp. (Toronto, 
ONT, Canada) and then diluted with DMEM plus 10% FBS plus P and S to the appropriate concentration 
used in our experiments. Both the LPS stock solution [3 ng/ml] and dilutions were stored at -80 °C, 
thawed prior to each experiment and discarded after use. 
 
4.2. LPS containment 
 
To inactivate extraneous LPS, all glassware and metal spatulas were baked for 4 hours at 180°C. 
Sterile and LPS-free 75-and 162-cm
2 vented cell culture flasks, 24-well flat-bottom culture clusters, 96-Mar. Drugs 2007, 5     129 
 
well cell culture clusters and disposable serological pipettes were purchased from Costar Corporation 
(Cambridge, MA), while polystyrene cell culture dishes (60 x 15 mm) were obtained from Corning 
Glass Works (Corning, NY). Sterile and pyrogen-free Eppendorf Biopur pipette tips were purchased 
from Brinkmann Instruments, Inc. (Westbury, NY). 
 
4.3. Nuclear magnetic resonance spectrometry of domoic acid 
 
The presence of undegraded domoic acid in the stock solution (12.5 mM) was confirmed by nuclear 
magnetic resonance (NMR) spectrometry prior to the experiments. NMR was performed in the 
Division of Biomedical Marine Research, Harbor Branch Oceanographic Institution, Fort Pierce, 
Florida. Two control samples were combined and freeze-dried yielding a white residue (750 mg). A 
portion of the white residue (1.0 mg) was re-dissolved in 0.5 ml of D2O for NMR studies. The proton 
NMR spectrum was measured on a Bruker AMX-500 instrument and chemical shifts were referenced 
to sodium-3-trimethylpropionate-d4 (TSP) signal observed at 4.69 ppm.  
 
4.4. Isolation and culture of rat neonatal microglia 
 
All experiments were performed with adherence to the National Institutes of Health guidelines on 
the use of experimental animals and with protocols approved by Midwestern University's Research and 
Animal Care Committee. To isolate rat neonatal microglia, cerebral cortices of 1-2 day-old Sprague-
Dawley rats purchased from Harlan (Indianapolis, IN) were surgically removed and placed in cold 
DMEM + 120 U/ml P and 12 μg/ml S, the meninges carefully removed, and brain tissue minced and 
dissociated with trypsin-EDTA at 36°C for 3-5 min. The mixed glial cell suspension was plated in 
either 75- or 162-cm
2 vented cell culture flasks with DMEM medium supplemented with 10% FBS + 
120 U/ml P + 12 μg/ml S and grown in a humidified 5% CO2 incubator at 36°C for 12-14 days. On 
day 14 and every week thereafter, microglia were detached using an orbital shaker (150 rpm, 0.5 
hours, 36°C, 5% CO2), centrifuged (400 x g, 25 min, 4°C), and microglia number and viability 
assessed by trypan blue exclusion. Microglia were characterized as described earlier [5]. Depending on 
the particular experimental protocol (see below), microglia averaging > than 95% viability were plated 
in either 60 mm x 15 mm polystyrene cell culture dishes, 96-well cell culture clusters, or 24-well cell 
culture clusters, with DMEM supplemented with 10% FBS + 120 U/ml P + 12 μg/ml S, and placed in 
a humidified 5% CO2 incubator at 36°C 18- 24 hours prior to the experiments. 
 
4.5. Experimental protocol to determine the effect of domoic acid and LPS on rat neonatal microglia 
TNF-α , TGF-β1 and MMP-9 
 
To study the time-dependent effects of domoic acid and LPS on TNF-α, TGF-β1 and MMP-9, rat 
neonatal microglia (2.8-5 x 10
6 cells/60 mm x 15 mm polystyrene cell culture dish) were treated with 
(1) domoic acid [1mM], (2) LPS-free water used as a vehicle for domoic acid or (3) LPS [3 ng/ml] in a 
final volume of 3 ml of DMEM supplemented with 10% FBS + 120 U/ml P + 12 μg/ml S and 
incubated in a humidified 5% CO2 incubator at 36°C for 4, 8, 16 and 24 h. Upon termination of the Mar. Drugs 2007, 5     130 
 
experiments, rat neonatal microglia were processed for RNA isolation and RT-PCR and the cell-free 
supernatants from each culture dish were assayed for TNF-α, TGF-β1 and MMP-9 ( see below). 
 
4.6. Experimental protocol to determine the effect of domoic acid and LPS on rat neonatal microglia 
TNF- α, TGF-β1 and MMP-9 expression: RNA isolation and semiquantitative RT-PCR analysis 
 
Total rat neonatal microglia RNA was isolated after treatment with either LPS or domoic acid for 4, 
8, 16 and 24 hours with TRI reagent purchased from Molecular Research Center, Inc. (Cincinnati, 
OH). The RT-PCR was performed in the same sample tube using gene-specific primers obtained from 
IDT (Coralville, IA), as described below, and the Superscript one-step kit obtained from Gibco-BRL 
(Grand Island, NY). Briefly, first strand cDNA was made using 0.25 μg of RNA, Superscript II H-
reverse transcriptase, antisense gene-specific primers and conditions of 30 min at 50 °C. Samples were 
denatured at 94 °C for 2 min , and PCR was performed for various cycle numbers to ensure linear 
amplification. The PCR cycling conditions consisted of a denaturation step at 94 °C for 30 s, an 
annealing step at 54 °C (S12), 60 °C (TNF-α), 61 °C (MMP-9), and 58.5 °C (TGF-β1), an extension 
step at 72 °C for 1 min, and a final extension step at 72 °C for 10 min. The 50 μl samples contained 0.2 
mM of each dNTP, 1.2 mM magnesium sulfate, Platinum® taq DNA polymerase, and 0.2 μM of each 
gene specific primer. The primers for rat TNF-α, were as previously described and generate a 181 bp 
cDNA product [27]. The sequences of the primers for rat TGF-β1 (GenBank accession number 
NM_021578) are sense (bp 785 - 808) 5’-ATA CAG GGC TTT CGC TTC AGT GCT-3’ and 
antisense (bp 1168 - 1191) 5’-CCC GGG TTG TGT TGG TTG TAG AGG-3’ and generate a 407 bp 
cDNA product. The rat MMP-9 (GenBank accession number NM_031055) primer sequences are sense 
(bp 509 – 528) 5’-AGT TTG GTG TCG CGG AGC AC-3’ and antisense (bp 1243 - 1262) 5’-TAC 
ATG AGC GCT TCC GGC AC-3’ and generate a 750 bp cDNA product. The primers for rat 
constitutively expressed ribosomal S12, are sense:5’-ACG TCA ACA CTG CTC TAC A-3’ and 
antisense:5’-CTT TGC CAT AGT CCT TAA C-3’ and generate a 303 bp cDNA product as previously 
described [54]. Controls for RT-PCR included samples without the enzyme reverse transcriptase and 
samples without template. The PCR reactions were analyzed by electrophoresis using 1.5 % agarose 
gels, visualized with SYBR® Gold nucleic acid staining (Molecular Probes; Eugene, OR), 
photographed, scanned and digitized with the UN-SCAN-IT™ gel automated digitizing system from 
Silk Scientific (Orem, UT). The relative amounts of TNF-α expression as determined by RT-PCR 
were normalized to S12 levels using methods similar to those previously described by others [55].  
 
4.7. Assays for TNF-α and TGF-β1 
 
Immunoreactive TNF-α and TGF-β1 in cell-free media supernates was determined using rat-
specific ELISAs purchased from Biosource International (Camarillo, CA) with a detection limit of 0.7 
pg/ml (TNF-α) and 15.6 pg/mL (TGF-β1). Results are expressed as pg/ml.  
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4.8. SDS-PAGE gelatinase zymography for MMP-2 and MMP-9 analysis 
 
Following incubation with LPS or domoic acid, MMP expression was analyzed in the harvested 
media of cultured rat neonatal microglia. As the rat neonatal microglia cultures were normalized for 
cell number, equal volumes of harvested media obtained from each condition were analyzed. Briefly, 
10 μl of each sample were electrophoresed at 4°C and under non-denaturing conditions using a 10% 
polyacrylamide gel containing 0.05% gelatin. The gels were incubated for 1 hour in a 2.5% Triton X-
100 solution and then washed twice with water (20 min each). The gels were then incubated for 24 
hours at 37°C in 50 mM Tris-HCl buffer, pH 7.4, containing 5 mM CaCl2. A duplicate negative 
control gel was incubated as described above but in 50 mM Tris-HCl, pH 7.4 containing 10 mM 
EDTA instead of CaCl2. The gels were fixed for 1 hour in 40% methanol /7% acetic acid and then 
stained in Coomassie Blue Solution (Sigma), followed by destaining in 10% methanol, 7% acetic acid. 
MMP activity was visualized as clear bands against a blue background. Gelatin-containing zymograms 
are typically used to detect MMP-2 (72 kDa) and MMP-9 (92 kDa) and their identification is based on 
molecular weight. Relative clearing of each sample was quantitated by determining the inverse optical 
density units using the NIH Image software package (version 1.60). Values are represented as the 
mean ± SE and are presented as inverse optical density. The value corresponding to background, a 
region of equal area as that used to measure the cleared bands and of a lane in which no sample was 
loaded, was subtracted from each sample value. 
 
4.9. Statistical analysis of the data 
 
Data were analyzed with Prism
R software package (GraphPad, San Diego, CA.) and SPSS version 15 
(SPSS Inc., Chicago, IL.). One way analysis of variance followed by either the LSD (Figure 3) or 
Dunnett's post hoc procedure was performed on all sets of data. LPS or domoic acid-treated groups were 
compared with the vehicle-treated group, shown as 0 or control in the corresponding figures. Differences 
were considered statistically significant at p<0.05 and reported in each figure legend. 
 
5. List of abbreviations 
 
AMPA,  α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid;  DMEM, Dulbecco's modified 
Eagle medium; DOM, domoic acid; FBS, fetal bovine serum certified; FCC, ferricytochrome c type III; 
HBSS, Hank’s balanced salt solution; LPS, lipopolysaccharide; MMP-9, matrix metalloproteinase-9; P, 
penicillin; PBS, phosphate buffered saline; PMA, phorbol 12-myristate 13-acetate ; RT-PCR, reverse 
transcriptase polymerase chain reaction; S, streptomycin; SE, standard error of the mean; SOD, 
superoxide dismutase; TGF-β1, transforming growth factor β1; TNF-α, tumor necrosis factor. 
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